Seaport Therapeutics is seeking a talented Program Leader (PL) to be a strategic leader who is responsible for establishing the long-term vision and strategy, and achieving strong execution of the SPT-300 Program in order to maximize its future clinical and commercial success in the treatment of depression. The SPT-300 program is entering into a Phase 2 study and the PL will lead the program to execute the current plans within timelines/budget an...
